Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery · Richmond, VA
NPI
1689873929
Since 2007
Specialty
Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery
Code 207VF0040X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
9101 Stony Point Dr
Richmond, VA, 23235
Phone (804) 330-9105
Groups this clinician bills Medicare through
Medicare paid, 2024
$221K
5,522 services
Medicare patients, 2024
1,206
Average age 76
Drug cost, 2024
$881K
2,861 prescriptions
Company payments, 2025
$843
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meghana Gowda was code 99214 (office e&m - established), 1,269 times for 884 patients. In total Meghana Gowda billed 5,522 services in 52 codes, and Medicare paid $221K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,269 | 884 | $88.28 | $112K |
| 81000 Clinical Chemistry | Office | 1,219 | 878 | $3.93 | $4,796 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 976 | 743 | $12.51 | $12K |
| 51798 Ultrasound - Nonspecific | Office | 453 | 409 | $8.18 | $3,705 |
| 81002 Clinical Chemistry | Office | 291 | 243 | $3.41 | $992 |
| 99204 Office E&M - New | Office | 291 | 291 | $118.47 | $34K |
| 99213 Office E&M - Established | Office | 231 | 204 | $57.68 | $13K |
| 97112 PT Treatment | Office | 70 | 19 | $21.61 | $1,513 |
| 99459 Office/Outpatient Services | Office | 42 | 41 | $17.84 | $749 |
| 52287 Cystourethroscopy | Facility | 39 | 31 | $121.23 | $4,728 |
| A4562 Pessary, reusable, non rubber, any type | Office | 23 | 19 | $50.84 | $1,169 |
| 57160 Other Organ Systems | Office | 18 | 16 | $58.10 | $1,046 |
| 64561 Neurostimulator - Back | Facility | 16 | 13 | $282.35 | $4,518 |
| 52204 Cystourethroscopy | Facility | 16 | 16 | $102.23 | $1,636 |
| 36415 Venipuncture Blood Collection | Office | 15 | 13 | $8.65 | $130 |
By year: 2022 $229K for 4,910 services; 2023 $259K for 5,193 services; 2024 $221K for 5,522 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 1,219 | 878 | $3.93 | $4,796 |
| 81002 Clinical Chemistry | 291 | 243 | $3.41 | $992 |
| 36415 Venipuncture Blood Collection | 15 | 13 | $8.65 | $130 |
Medicare prescription drug claims, 2024
In 2024, the drug Meghana Gowda prescribed most often to Medicare patients was Myrbetriq (Mirabegron), with 735 prescriptions and refills. In total Meghana Gowda wrote 2,861 Medicare prescriptions that cost $881K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | 735 | 1,148 | 214 | $510K |
| Estradiol Generic | 491 | 1,178 | 311 | $30K |
| Trospium Chloride Generic | 360 | 643 | 142 | $27K |
| Gemtesa Vibegron | 267 | 425 | 72 | $200K |
| Methenamine Hippurate Generic | 182 | 423 | 82 | $16K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 169 | 171 | 146 | $1,551 |
| Trospium Chloride Er Trospium Chloride | 140 | 314 | 40 | $31K |
| Ciprofloxacin Hcl Generic | 137 | 137 | 122 | $559 |
| Mirabegron Er Mirabegron | 76 | 159 | 38 | $51K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 45 | 75 | 21 | $963 |
| Fluconazole Generic | 34 | 34 | 23 | $141 |
| Cephalexin Generic | 28 | 59 | 17 | $240 |
| Yuvafem Estradiol | 24 | 40 | Under 11 | $3,107 |
| Trimethoprim Generic | 23 | 36 | Under 11 | $614 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 22 | 22 | 22 | $87.56 |
Brand drugs: - claims; generic drugs: 1,775 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meghana Gowda $843 ($843 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $149.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $149 |
| Procept Biorobotics Corporation PRCT | 1 | $133 |
| Janssen Biotech, Inc. JNJ | 4 | $96.17 |
| Blue Earth Diagnostics | 3 | $76.6 |
| Urogen Pharma, Inc. URGN | 2 | $55.82 |
| Endo USA, Inc. | 2 | $44.61 |
| Teleflex LLC TFX | 2 | $43.66 |
| Bioprotect Medical, Inc. | 1 | $40.71 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $31.89 |
| Cardinal Health 414 LLC | 1 | $30.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.